Companies: 10,795·Total market cap: $144.5T
Enveric Biosciences, Inc.

Enveric Biosciences, Inc.

ENVBNASDAQHealthcare● Active
$1.75
$-0.05(-2.78%)
Market Cap$1044771
P/E Ratio
52W High$17.64
52W Low$1.66

Enveric Biosciences, Inc. (ENVB) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · ENVB · as of Jun 9, 2026

Activity summary

Buy transactions

1

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

Enveric Biosciences, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

ENVB insider buying and selling by quarter

ENVB insider selling · ENVB insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
1.9M936K0
2023 Q3
2024 Q1
2024 Q2
2024 Q4

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · ENVB ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

ENVB executive sell shares · ENVB board member insider trading · ENVB insider trading SEC filing

Showing 59 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

DeWitt Sheila

Director

Award

Date

Dec 23

Shares

7,633

Price

Value

View Form 4 on SEC.gov

Kegler George A.

Director

Award

Date

Dec 23

Shares

7,633

Price

Value

View Form 4 on SEC.gov

PASQUALONE FRANK

Director

Award

Date

Dec 23

Shares

7,633

Price

Value

View Form 4 on SEC.gov

Schabacker Marcus

Director

Award

Date

Dec 23

Shares

7,633

Price

Value

View Form 4 on SEC.gov

Tucker Joseph Edward

CEO · Director

Award

Date

Dec 23

Shares

60,296

Price

Value

View Form 4 on SEC.gov

WEBB MICHAEL D

Director

Award

Date

Dec 23

Shares

7,633

Price

Value

View Form 4 on SEC.gov

Coveney Kevin Michael

CFO

Award

Date

Dec 23

Shares

40,198

Price

Value

View Form 4 on SEC.gov

Coveney Kevin Michael

CHIEF FINANCIAL OFFICER

Award

Date

May 8

Shares

74,150

Price

Value

View Form 4 on SEC.gov

Facchini Peter J.

CHIEF INNOVATION OFFICER

Award

Date

May 8

Shares

24,717

Price

Value

View Form 4 on SEC.gov

Tucker Joseph Edward

CHIEF EXECUTIVE OFFICER · Director

Award

Date

May 8

Shares

98,866

Price

Value

View Form 4 on SEC.gov

DeWitt Sheila

Director

Award

Date

Oct 9

Shares

27,845

Price

Value

View Form 4 on SEC.gov

Kegler George A.

Director

Award

Date

Oct 9

Shares

47,733

Price

Value

View Form 4 on SEC.gov

Schabacker Marcus

Director

Award

Date

Oct 9

Shares

47,733

Price

Value

View Form 4 on SEC.gov

WEBB MICHAEL D

Director

Award

Date

Oct 9

Shares

47,733

Price

Value

View Form 4 on SEC.gov

PASQUALONE FRANK

Director

Award

Date

Oct 9

Shares

47,733

Price

Value

View Form 4 on SEC.gov

Tucker Joseph Edward

CHIEF EXECUTIVE OFFICER · Director

Award

Date

Oct 9

Shares

161,633

Price

Value

View Form 4 on SEC.gov

Facchini Peter J.

CHIEF INNOVATION OFFICER

Award

Date

Oct 9

Shares

40,000

Price

Value

View Form 4 on SEC.gov

Coveney Kevin Michael

CHIEF FINANCIAL OFFICER

Award

Date

Oct 9

Shares

100,000

Price

Value

View Form 4 on SEC.gov

Tucker Joseph Edward

CHIEF EXECUTIVE OFFICER · Director

Award

Date

Feb 22

Shares

100,000

Price

Value

View Form 4 on SEC.gov

Facchini Peter J.

CHIEF INNOVATION OFFICER

Award

Date

Feb 22

Shares

50,000

Price

Value

View Form 4 on SEC.gov

Coveney Kevin Michael

CHIEF FINANCIAL OFFICER

Award

Date

Feb 22

Shares

60,000

Price

Value

View Form 4 on SEC.gov

PASQUALONE FRANK

Director

Purchase

Date

Sep 15

Shares

1,000

Price

$2.14

Value

$2K

View Form 4 on SEC.gov

Coveney Kevin Michael

CFO

Award

Date

Mar 13

Shares

26,500

Price

Value

View Form 4 on SEC.gov

Facchini Peter J.

Chief Innovation Officer

Award

Date

Jan 25

Shares

17,000

Price

Value

View Form 4 on SEC.gov

Hagel Jillian Marie

Vice President of Innovation

Award

Date

Jan 25

Shares

12,000

Price

Value

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About ENVB insider trading

ENVB insider trades

Enveric Biosciences, Inc. (ENVB) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including DeWitt Sheila (Director), Kegler George A. (Director), PASQUALONE FRANK (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. ENVB insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Enveric Biosciences, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

ENVB insider trading · 5 questions

The insiders of Enveric Biosciences, Inc. (ENVB) include executives and directors such as DeWitt Sheila (Director), Kegler George A. (Director), PASQUALONE FRANK (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

ENVB board member insider tradingwho are ENVB insidersENVB insider rosterEnveric Biosciences, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026